Financial News Feed

Previous Hold Today ALXN ranks #2890 as HOLD CANDIDATE #2890 Next Hold

Alexion Pharmaceuticals stock forecast

ALXN stock forecast

Alexion (ALXN) reports positive data on Ultomiris in adult patients with paroxysmal nocturnal hemoglobinuria....

Read more

Alexion (ALXN) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues....

Read more

Alexion (ALXN) gains 30.7% on solid performance of lead drug Soliris and approval of Ultomiris....

Read more

Alexion (ALXN) could produce exceptional returns because of its solid growth attributes....

Read more

What Makes Alexion (ALXN) a New Buy Stock
01:00pm, Thursday, 09'th May 2019
Alexion (ALXN) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy)....

Read more

Uber Time (Stocks To Watch Podcast)
12:00pm, Sunday, 05'th May 2019
No summary available....

Read more

No summary available....

Read more

No summary available....

Read more

No summary available....

Read more

No summary available....

Read more

No summary available....

Read more

No summary available....

Read more

No summary available....

Read more

Proudly made at

Rise Vilnius
in partnership with
Barclays Bank